ProfileGDS4718 / 230538_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 7% 9% 40% 8% 8% 10% 16% 10% 16% 9% 13% 9% 15% 6% 14% 16% 12% 16% 12% 13% 7% 10% 15% 11% 8% 8% 14% 12% 7% 14% 10% 12% 10% 15% 19% 13% 8% 8% 6% 23% 8% 15% 24% 11% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.693517
GSM549102patient 115, normal, homogenized [OPG study]3.743619
GSM549104patient 119, normal, homogenized [OPG study]4.9833740
GSM549108patient 138, normal, homogenized [OPG study]3.732768
GSM549119patient 077, normal, homogenized [OPG study]3.716538
GSM549133patient 032, cancer, homogenized [OPG study]3.7540610
GSM549139patient 042, cancer, homogenized [OPG study]3.9805416
GSM549099patient 107, normal, homogenized [OPG study]3.7814110
GSM549109patient 139, normal, homogenized [OPG study]4.0275416
GSM549110patient 046, normal, homogenized [OPG study]3.747779
GSM549114patient 063, normal, homogenized [OPG study]3.8653313
GSM549122patient 082, normal, homogenized [OPG study]3.747779
GSM549134patient 033, cancer, homogenized [OPG study]3.9735415
GSM549136patient 036, cancer, homogenized [OPG study]3.575636
GSM549140patient 044, cancer, homogenized [OPG study]3.898714
GSM549111patient 047, normal, homogenized [OPG study]3.957616
GSM549113patient 057, normal, homogenized [OPG study]3.8085212
GSM549132patient 031, cancer, homogenized [OPG study]3.9888416
GSM549137patient 038, cancer, homogenized [OPG study]3.8479812
GSM549142patient 047, cancer, homogenized [OPG study]3.9514113
GSM549100patient 110, normal, homogenized [OPG study]3.68047
GSM549107patient 135, normal, homogenized [OPG study]3.7578910
GSM549115patient 068, normal, homogenized [OPG study]3.9294715
GSM549116patient 072, normal, homogenized [OPG study]3.8210411
GSM549120patient 078, normal, homogenized [OPG study]3.716168
GSM549131patient 030, cancer, homogenized [OPG study]3.665138
GSM549118patient 074, normal, homogenized [OPG study]3.9291214
GSM549129patient 027, cancer, homogenized [OPG study]3.8514512
GSM549123patient 088, normal, homogenized [OPG study]3.687167
GSM549124patient 006, cancer, homogenized [OPG study]3.9430714
GSM549126patient 015, cancer, homogenized [OPG study]3.7809710
GSM549128patient 025, cancer, homogenized [OPG study]3.8342712
GSM549103patient 117, normal, homogenized [OPG study]3.8199810
GSM549117patient 073, normal, homogenized [OPG study]3.96115
GSM549138patient 041, cancer, homogenized [OPG study]4.0901619
GSM549141patient 045, cancer, homogenized [OPG study]3.8286313
GSM549130patient 028, cancer, homogenized [OPG study]3.715488
GSM549101patient 111, normal, homogenized [OPG study]3.687538
GSM549105patient 128, normal, homogenized [OPG study]3.613826
GSM549106patient 134, normal, homogenized [OPG study]4.1973123
GSM549112patient 048, normal, homogenized [OPG study]3.708618
GSM549125patient 011, cancer, homogenized [OPG study]3.9721515
GSM549127patient 024, cancer, homogenized [OPG study]4.2867124
GSM549135patient 035, cancer, homogenized [OPG study]3.7601611